First Reported Case of Pulmonary Arterial Hypertension Secondary to Tofacitinib Treatment for Undifferentiated Arthritis

J Clin Rheumatol. 2021 Jun 1;27(4):e136-e138. doi: 10.1097/RHU.0000000000000889.
No abstract available

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis* / chemically induced
  • Arthritis* / diagnosis
  • Arthritis* / drug therapy
  • Humans
  • Piperidines
  • Pulmonary Arterial Hypertension*
  • Pyrimidines / adverse effects
  • Pyrroles / adverse effects
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib